Educating doctors on the benefits of Clozapine for treating treatment resistant schizophrenia

Clozapine is the most effective medication known for treatment resistant schizophrenia, but it’s under prescribed. The Maryland Psychiatric Research Center is working to change that by reaching out to health care providers through a telementoring program. In this video, Dr. Deanna Kelly explains how the Echo Project will educate doctors about the benefits of Clozapine and how to address side effects and patient monitoring. The University of Maryland School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond.